We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+35.16%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$20.1B
AUM Growth
+$3.92B
Cap. Flow
-$253M
Cap. Flow %
-1.26%
Top 10 Hldgs %
28.27%
Holding
390
New
38
Increased
100
Reduced
186
Closed
43

Top Buys

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$108M
2
ASAN icon
Asana
ASAN
+$77.4M
3
PINS icon
Pinterest
PINS
+$73.2M
4
ONEM
1Life Healthcare
ONEM
+$65.8M
5
TWLO icon
Twilio
TWLO
+$57.3M

Top Sells

Rank Stock Value
1
LVGO
Livongo Health, Inc. Common Stock
LVGO
+$204M
2
RNG icon
RingCentral
RNG
+$139M
3
TSLA icon
Tesla
TSLA
+$114M
4
DXCM icon
DexCom
DXCM
+$70M
5
ZM icon
Zoom
ZM
+$64.7M

Sector Composition

Rank Sector Weight
1 Technology 27.93%
2 Healthcare 23.77%
3 Consumer Discretionary 20.21%
4 Communication Services 12.3%
5 Miscellaneous 5.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDFN
101
DELISTED
Redfin
RDFN
$45.6M 0.23%
664,766
-9,211
-1% -$492K
ABNB icon
102
Airbnb
ABNB
$101B
$45.3M 0.23%
+308,805
New +$45.6M
EIDX
103
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$43.8M 0.22%
333,176
-2,173
-0.6% -$192K
SSNC icon
104
SS&C Technologies
SSNC
$18.8B
$43.2M 0.21%
594,428
-5,099
-0.9% -$342K
PI icon
105
Impinj
PI
$5.4B
$43.1M 0.21%
1,030,466
+550,274
+115% +$19.2M
PRPL icon
106
Purple Innovation
PRPL
$14.2M
$42.7M 0.21%
51,797
+9,756
+23% +$7.11M
ABMD
107
DELISTED
Abiomed Inc
ABMD
$41.1M 0.2%
126,849
-1,325
-1% -$366K
RSVAU
108
DELISTED
Rodgers Silicon Valley Acquisition Corp. Unit
RSVAU
$40.9M 0.2%
+3,066,627
New +$37.5M
RNLX
109
DELISTED
Renalytix plc American Depositary Shares
RNLX
$40.8M 0.2%
2,550,740
+51,208
+2% +$632K
SITE icon
110
SiteOne Landscape Supply
SITE
$4.05B
$40.2M 0.2%
253,457
-1,526
-0.6% -$209K
PRVB
111
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$40M 0.2%
2,359,682
+208,280
+10% +$3.12M
ARGX icon
112
argenx
ARGX
$61.6B
$39.8M 0.2%
135,420
-1,359
-1% -$374K
CHWY icon
113
Chewy
CHWY
$8.58B
$39.7M 0.2%
441,834
+70,165
+19% +$5.12M
CRM icon
114
Salesforce
CRM
$214B
$39M 0.19%
175,291
-3,528
-2% -$858K
XYL icon
115
Xylem
XYL
$25.1B
$36.4M 0.18%
357,971
-4,360
-1% -$410K
META icon
116
Meta Platforms (Facebook)
META
$1.7T
$35.1M 0.17%
128,622
-179,950
-58% -$49.3M
CELH icon
117
Celsius Holdings
CELH
$7.2B
$34.7M 0.17%
2,066,235
+491,829
+31% +$4.91M
PDD icon
118
Pinduoduo
PDD
$113B
$33.1M 0.16%
186,454
-64,183
-26% -$7.67M
DNTH icon
119
Dianthus Therapeutics
DNTH
$6.02B
$33.1M 0.16%
263,638
-2,942
-1% -$334K
SGTX
120
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$31.8M 0.16%
+50,941
New +$23.1M
MAG
121
DELISTED
MAG Silver
MAG
$31.7M 0.16%
1,544,260
-41,401
-3% -$713K
ALEC icon
122
Alector
ALEC
$239M
$31M 0.15%
2,052,028
-109,792
-5% -$1.36M
API
123
Agora
API
$343M
$30.6M 0.15%
773,221
+516,239
+201% +$21.3M
ONEW icon
124
OneWater Marine
ONEW
$179M
$29.9M 0.15%
1,028,277
+101,725
+11% +$2.44M
LESL icon
125
Leslie's
LESL
$4.61M
$29.5M 0.15%
+53,182
New +$23.9M

Similar funds

Gilder Gagnon Howe & Co's Q4 2020 Portfolio in Review

As of Q4 2020, Gilder Gagnon Howe & Co held 390 positions worth $20.1B, up 24% from $16.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Gilder Gagnon Howe & Co's Q4 2020 filing shows 38 new, 100 increased, 186 reduced and 43 closed positions. Its largest new stake was Asana: 3,026,048 shares worth $89.4M. The largest sale was Livongo Health, Inc. Common Stock, an estimated $204M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Gilder Gagnon Howe & Co's largest Q4 2020 buy was Asana: 3,026,048 shares worth $89.4M.
  • Gilder Gagnon Howe & Co added most to Teladoc Health in Q4 2020, an estimated $108M increase.
  • Gilder Gagnon Howe & Co's biggest Q4 2020 reduction was RingCentral, cutting an estimated $139M.
  • Gilder Gagnon Howe & Co fully exited Livongo Health, Inc. Common Stock in Q4 2020, selling an estimated $204M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 28% of its $20.1B portfolio in Q4 2020.
  • Gilder Gagnon Howe & Co opened 38 new positions and closed 43 in Q4 2020.
  • Gilder Gagnon Howe & Co's portfolio value rose 24% quarter-over-quarter to $20.1B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2020, filed 16 Feb 2021.